Nrf2-Dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer

S. C. Hwang, Y. J. Jung, W. Y. Jung, K. S. Lee, J. H. Park, Y. S. Kim, H. L. Lee, K. J. Park (Suwon, Republic Of Korea)

Source: Annual Congress 2010 - Pathology of lung cancer
Session: Pathology of lung cancer
Session type: Thematic Poster Session
Number: 3269
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. C. Hwang, Y. J. Jung, W. Y. Jung, K. S. Lee, J. H. Park, Y. S. Kim, H. L. Lee, K. J. Park (Suwon, Republic Of Korea). Nrf2-Dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer. Eur Respir J 2010; 36: Suppl. 54, 3269

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Expression of peroxiredoxin I, III and thioredoxin in human lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 102s
Year: 2005

Activation of NRF2 is responsible for the overexpression of peroxiredoxin and sulphiredoxin in human lung cancer
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Decreased mRNA and protein expression of peroxiredoxin (PRDX6) in the COPD lung
Source: Eur Respir J 2004; 24: Suppl. 48, 320s
Year: 2004

Adenovirus-mediated AP-2α down-regulates MnSOD expression in lung cancer A549 cells and its molecular mechanism
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011

Inhibition of heme oxygenase-1 enhances chemosensitivity of cisplatin in lung cancer cells
Source: Eur Respir J 2006; 28: Suppl. 50, 336s
Year: 2006

Expression of p53, Bcl-2 and Bax in non-small cell lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 512s
Year: 2007

Polymorphisms A1026G and G369C of CDKN1A/p21 and p53 genes in lung cancer
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011

Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis
Source: Eur Respir J 2002; 20: 703-709
Year: 2002



Diminished expression of HOXA5 in lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 256s
Year: 2003

PP138 – Regulation of PA200 in lung cancer
Source: ERS Lung Science Conference 2021
Year: 2021

Regulation of PA200 in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Transcriptional regulation of the human osteopontin promoter in non-small cell lung cancer
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011

Inhibitory effects of mitochondrial TRAP1 on gefitinib-resistancein non-small lung cancer cells
Source: International Congress 2018 – Lung cancer: novel molecular markers and mechanisms
Year: 2018



Mutant P53 expression in squamous cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 72s
Year: 2002

The role of peroxiredoxins in the radiation-induced damage of lung cancer cells
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007


ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumour metastasis
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 810s
Year: 2006

Distinct forms of BARD1 expressed in lung fibrosis and lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 325s
Year: 2006

Expression of Her-2/neu and Bcl-2 in patients with non-small cell lung cancer
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017

Fusion transcripts in lung cancer
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017